Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the therapeutic success on day 28 is lower than studies in Southwestern India (100%), Central China (100%), Brazil (100%), and Colombia (98.6%) [27–30], as well as two Ethiopian studies (Arbamich 100%, Bishoftu-Adama 99.2%) [31, 32], the day 42 success rate in this study is comparable to findings from Arbamich [31] but lower than those from India (100%) and China (96.1%) [33, 34].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snounou, G., Viriyakosol, S., Zhu, X. P., Jarra, W., Pinheiro, L., do Rosario, V. E., Thaithong, S., & Brown, K. N. (1993) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(93)90077-b · Cited by 1,591
Research works printed but not linked: 21
- A Nandy, 2003, Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India, Ann Trop Med Parasitol, 97, 215, 10.1179/000349803235001868 · DOI
- K Rishikesh, 2015, Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India, Malar J, 14, 310, 10.1186/s12936-015-0824-y · DOI
- RK Singh, 2000, Emergence of chloroquine-resistant vivax malaria in south Bihar (India), Trans R Soc Trop Med Hyg, 94, 327, 10.1016/S0035-9203(00)90344-4 · DOI · Paper page
- VK Dua, 1996, Chloroquine resistant Plasmodium vivax malaria in India, Trop Med Int Health, 1, 816, 10.1111/j.1365-3156.1996.tb00116.x · DOI
- M Garg, 1995, Vivax malaria resistant to chloroquine: case reports from Bombay, Trans R Soc Trop Med Hyg, 89, 656, 10.1016/0035-9203(95)90432-8 · DOI
- H Joshi, 2008, Plasmodium vivax in India, Trends in parasitology, 24, 228, 10.1016/j.pt.2008.01.007 · doi:10.1016/j.pt.2008.01.007
- E Beutler, 1966, A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood, 28, 553, 10.1182/blood.V28.4.553.553 · DOI
- K Rishikesh, 2015, Surmised total leucocyte counts miscalculate the parasite index of Plasmodium vivax malaria patients of tertiary and primary care settings in South-Western India, Malar J, 14, 163, 10.1186/s12936-015-0669-4 · DOI
- K Saravu, 2014, Risk Factors and Outcomes Stratified by Severity of Acute Kidney Injury in Malaria, PloS one, 9, e90419, 10.1371/journal.pone.0090419 · DOI
- K Saravu, 2014, Severity in Plasmodium vivax malaria claiming global vigilance and exploration-a tertiary care centre-based cohort study, Malar J, 13, 304, 10.1186/1475-2875-13-304 · DOI
- K Saravu, 2014, Determinants of mortality, intensive care requirement and prolonged hospitalization in malaria—a tertiary care hospital based cohort study from South-Western India, Malar J, 13, 370, 10.1186/1475-2875-13-370 · DOI
- L Yuan, 2015, Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar, Antimicrob Agents Chemother, 59, 1230, 10.1128/AAC.04270-14 · DOI · Paper page
- W Maneeboonyang, 2011, Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border, Southeast Asian J Trop Med Public Health, 42, 9
- R Takeuchi, 2010, Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border, Malar J, 9, 308, 10.1186/1475-2875-9-308 · DOI
- T Leslie, 2004, Compliance with 14-day primaquine therapy for radical cure of vivax malaria—a randomized placebo-controlled trial comparing unsupervised with supervised treatment, Trans R Soc Trop Med Hyg, 98, 168, 10.1016/S0035-9203(03)00041-5 · DOI · Paper page
- S Ganguly, 2013, In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes, Antimicrob Agents Chemother, 57, 1246, 10.1128/AAC.02050-12 · DOI · Paper page
- Y Poravuth, 2011, Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial, PLoS One, 6, e14501, 10.1371/journal.pone.0014501 · DOI
- S Shalini, 2014, Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India, Malar J, 13, 129, 10.1186/1475-2875-13-129 · DOI
- HC Srivastava, 2008, Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates, Ann Trop Med Parasitol, 102, 471, 10.1179/136485908X311759 · DOI
- AP Phyo, 2011, Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial, Clin Infect Dis, 53, 977, 10.1093/cid/cir631 · DOI · Paper page
- GT Phan, 2002, Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam, Trop Med Int Health, 7, 858, 10.1046/j.1365-3156.2002.00948.x · DOI
Cited by
Getu, E., Biruksew, A., Eshetu, T., Abamecha, A., Assefa, D. G., Mohammed, H., Wuletaw, Y., Tasew, G., Tollera, G., Hailu, M., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05446-y · Cited by 4
Metadata
- Authors
- Saravu, K., Kumar, R., Ashok, H., Kundapura, P., Kamath, V., Kamath, A., & Mukhopadhyay, C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-06-17
- Volume
- 11
- Issue
- 6
- Pages
- e0157666
- ISSN
- 1932-6203
- Cited by
- 34
- References
- 1
- Language
- en
- Funders
- Indian Council of Medical Research (AMR/46/2011-ECD-I, 80/931/2015-ECD-I)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.